Text with patent numbers: |
|
||||||||||||||||||||||||
Title: | |||||||||||||||||||||||||
Abstract: | |||||||||||||||||||||||||
Specification: | |||||||||||||||||||||||||
Claims: | |||||||||||||||||||||||||
Inventor: | |||||||||||||||||||||||||
Assg. orig: | |||||||||||||||||||||||||
Assg. curr: | |||||||||||||||||||||||||
Expiry from: | to: | ||||||||||||||||||||||||
Priority from:sa | to: | ||||||||||||||||||||||||
Ref. by: | and more | Ind.cl: | and shorter | ||||||||||||||||||||||
Entity: | Type: | Expired: | Maint.status: | ||||||||||||||||||||||
Score from: | % to: % | Current assig. owns from to patents |
patent | score | priority | expiry | expired | references | current assignee | title |
---|---|---|---|---|---|---|---|
7053089 | 6 | 2001-02-23 | 2022-06-03 | 1 | 6 | Merck Sharp & Dohme LLC; | N-substituted nonaryl-heterocyclic NMDA/NR2B antagonists |
8540731 | 6 | 2008-09-29 | 2029-09-28 | 0 | 77 | SCHOLL S WELLNESS COMPANY LIMITED; | Skin treating device |
6773704 | 17 | 1999-10-28 | 2020-10-26 | 1 | 7 | BRIGHAM AND WOMEN S HOSPITAL, INC , THE; | Methods of treating vascular disease associated with cystatin C deficiency |
7189518 | 21 | 2001-11-05 | 2022-12-24 | 1 | 10 | BRIGHAM AND WOMEN S HOSPITAL, INC THE; | Soluble CD40L(CD154) as a prognostic marker of atherosclerotic diseases |
6044974 | 54 | 1998-12-04 | 2018-12-04 | 1 | 4 | Innovative Enterprises, Inc.; | Package for mating machine components |
8686226 | 57 | 2002-09-18 | 2024-07-31 | 1 | 2 | Mendel Biotechnology, Inc; | MYB-related transcriptional regulators that confer altered root hare, trichome morphology, and increased tolerance to abiotic stress in plants |
7217716 | 66 | 2001-02-23 | 2022-03-19 | 1 | 4 | Merck Sharp & Dohme Corp; | N-substituted nonaryl-heterocyclic NMDA/NR2B antagonists |
7939715 | 71 | 2001-03-30 | 2021-07-09 | 1 | 1 | Mendel Biotechnology, Inc; | Plants with improved yield and stress tolerance |
10266575 | 75 | 1998-09-22 | 2019-09-13 | 1 | 1 | Mendel Biotechnology, Inc.; | Plant transcriptional regulators |
6812205 | 76 | 2000-03-15 | 2022-04-19 | 1 | 0 | BRIGHAM AND WOMEN S HOSPITAL, INC , THE; | Suppression of vascular disorders by mucosal administration of heat shock protein peptides |
9856297 | 88 | 1999-03-23 | 2021-01-23 | 1 | 0 | Mendel Biotechnology, Inc.; | Plant transcriptional regulators |